Please login to the form below
Fishawack acquires creative consultancy Blue Latitude Health
The Fishawack Group has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency.
The Fishawack Group of Companies, one of the world’s largest independent medical communications and medical marketing organizations, has acquired Blue Latitude Health, based in London, UK, and New York, USA. Blue Latitude Health is a creative consultancy combining the commercial focus of a consultancy with the creative vision of an agency.
“In 2016, we set out our vision to form a major new force in the global creative agency space that would make us as strong in the creative arena as we already are in medical communications,” explained Oliver Dennis, Chief Executive Officer of the Fishawack Group. “With three acquisitions in this space in the last 16 months, I think we’ve firmly announced our intention to achieve this goal. We were actively looking for a consultancy that could bring strategic and customer experience expertise to our portfolio and Blue Latitude Health fits perfectly.”
“To enable us to continue to grow and provide existing and future clients with a stronger offering, we needed to find a partner who both shared our values and matched our ambition,” stated Martin Brass, Managing Director of Blue Latitude Health. “We believe we have found this partner in Fishawack.”
Fred Bassett, Head of Strategy and Co-founder of Blue Latitude Health, added “We are thrilled to join an organization with the global scale and extended services in medical and scientific communications that Fishawack offers.”
“Many of our clients are wanting a partner that has specialist global capabilities both commercially and medically, and can ensure alignment of communication objectives,” commented Gail Flockhart, Group Managing Director of Fishawack. “Blue Latitude Health has a deep strategic consulting capability and brings us a base in New York City, from which we can continue to expand our East Coast creative and medical communications teams.”
Fishawack received corporate finance and legal support from Rick Stark and Phil Hall of KPMG, and George Danczak and James Finney of Addleshaw Goddard LLP (UK), respectively.
Photo: Dominic Miller, Fred Bassett, Oliver Dennis (back row from left to right), Martin Brass, Gail Flockhart (front row from left to right).
Company Details
Fishawack Health
Address:
No. 3 Booths Park
Booths Hall
Chelford Road
Knutsford
Cheshire
WA16 8GS
United Kingdom
Latest content on this profile
- Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities
- As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.
Fishawack Health
- Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies
- Fishawack Health welcomes Harriet Shurville to the team as Chief People Officer to spearhead integration efforts, champion diversity and inclusion, and cultivate an environment where interdisciplinary teams thrive.
Fishawack Health
- Archetypes: Rethinking go-to-market expectations to drive commercial success
- In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the implications for products and portfolios across the development life cycle.
Fishawack Health
- Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer
- Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.
Fishawack Health
- Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
- Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts provide insights on the trends, challenges and opportunities for biopharmaceutical companies, including why an interdisciplinary approach is needed to improve outcomes in oncology.
Fishawack Health
- The challenges of reimbursement and innovative pricing for cell and gene therapies
- Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of innovative pricing models, including ensuring the model chosen meets the payer’s needs.
Fishawack Health
